Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar repair following LPS-induced injury requires cell-ECM interactions
Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa
Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa
View: Text | PDF
Research Article Cell biology Pulmonology

Alveolar repair following LPS-induced injury requires cell-ECM interactions

  • Text
  • PDF
Abstract

During alveolar repair, alveolar type 2 (AT2) epithelial cell progenitors rapidly proliferate and differentiate into flat AT1 epithelial cells. Failure of normal alveolar repair mechanisms can lead to loss of alveolar structure (emphysema) or development of fibrosis, depending on the type and severity of injury. To test if β1-containing integrins are required during repair following acute injury, we administered E. coli lipopolysaccharide (LPS) by intratracheal injection to mice with a postdevelopmental deletion of β1 integrin in AT2 cells. While control mice recovered from LPS injury without structural abnormalities, β1-deficient mice had more severe inflammation and developed emphysema. In addition, recovering alveoli were repopulated with an abundance of rounded epithelial cells coexpressing AT2 epithelial, AT1 epithelial, and mixed intermediate cell state markers, with few mature type 1 cells. AT2 cells deficient in β1 showed persistently increased proliferation after injury, which was blocked by inhibiting NF-κB activation in these cells. Lineage tracing experiments revealed that β1-deficient AT2 cells failed to differentiate into mature AT1 epithelial cells. Together, these findings demonstrate that functional alveolar repair after injury with terminal alveolar epithelial differentiation requires β1-containing integrins.

Authors

Jennifer M.S. Sucre, Fabian Bock, Nicholas M. Negretti, John T. Benjamin, Peter M. Gulleman, Xinyu Dong, Kimberly T. Ferguson, Christopher S. Jetter, Wei Han, Yang Liu, Seunghyi Kook, Jason J. Gokey, Susan H. Guttentag, Jonathan A. Kropski, Timothy S. Blackwell, Roy Zent, Erin J. Plosa

×

Figure 9

AT2s of mixed transcriptomic phenotype persist, proliferate, and maintain an enlarged, rounded cell shape in late alveolar repair.

Options: View larger image (or click on image) Download as PowerPoint
AT2s of mixed transcriptomic phenotype persist, proliferate, and maintai...
(A) UMAP of all epithelial cells from β1fl/fl and β1AT2-KO lungs 21 days after LPS treatment clustered by label transfer from Strunz et al. (11). (B) Individual epithelial populations by group reveal transcriptionally abundant AT2s and activated AT2s in day 21 LPS-treated β1AT2-KO lungs. (C) Hallmark gene expression by genotype in AT2, activated AT2, and Krt8 ADI clusters, in which higher expression is represented with a darker color and the size of the dot reflects the proportion of cells expressing that marker. (D) Representative low-power images of β1fl/fl and β1AT2-KO lungs 21 days after LPS co-immunostained for pro–SP-C (red), cytokeratin 8 (gold), AGER (cyan), and CD68 (blue). β1AT2-KO lungs are notable for enlarged airspaces and increased numbers of round, large pro–SP-C+ AT2 cells, which are distinct from alveolar macrophages. (E) High-power images of lung sections immunostained for pro–SP-C, cytokeratin 8, AGER, and CD68, as above, demonstrate round, large pro–SP-C+ AT2 cells that colocalize with cytokeratin 8, with a subset also triple positive (pro–SP-C+cytokeratin 8+AGER+). Arrow denotes occasional triple-positive cells in β1AT2-KO lungs, and arrowhead marks AGER– AT2 cells in β1fl/fl lungs. (F) Quantification of pro–SP-C+cytokeratin 8+AGER+ triple-positive cells as a percentage of total pro–SP-C+ cells in day 21 LPS-treated lungs (n = 6 mice/group, 10 original magnification, 60×, sections/mouse, P < 0.0001 by 2-tailed t test). * P < 0.05. Scale bar = 100 μm in D, 10 μm in E.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts